alexa Drug Development|omicsgroup|Journal Of Nanomedicine And Biotherapeutic Discovery|omicsgroup|Journal Of Nanomedicine And Biotherapeutic Discovery

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Drug Development

Drugs are substances that exert some kind of physiological or biochemical effect on our bodies. They may be single compounds or mixtures, and their effects may be beneficial or harmful. All drugs interact with specific targets, which are usually proteins but in some cases DNA or RNA. Drugs work either by stimulating or blocking the activity of their targets. Today, more systematic approaches are used. High-throughput screening is used to test thousands of potential targets with thousands of diverse chemical compounds in order to identify promising lead compounds (chemical entities that interact with targets and therefore have potential as drugs). The alternative method of rational drug design involves the design and synthesis of compounds based on the known structure of either a specific target or one of its natural ligands. The results of the Human Genome Project and human pathogen genome projects provide many new potential drug targets. For this reason, target identification must be followed by target validation, which confirms the likelihood that interfering with the target protein will impact on the disease. Open access journal articles are essentially peer-reviewed and available for access through the directory of Open Access journals. OMICS Group International supports this system and provides access to 300 Open Access journals with no restrictions and thus promotes the Open Access movement with a view to promote scientific advancements. The research articles published in OMICS Group journals are immediately and permanently available online without charge.
 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords